Naoko Minatani
Sagamihara, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Differential Prognostic Relevance of Promoter DNA Methylation of CDO1 and HOPX in Primary Breast Cancer.
Journal: Anticancer research
Published: March 25, 2019
Comprehensive Genetic Search to Clarify the Molecular Mechanism of Drug Resistance Identifies ASCL2-LEF1/TSPAN8 Axis in Colorectal Cancer.
Journal: Annals of surgical oncology
Published: October 22, 2018
Lymph node metastasis and high serum CEA are important prognostic factors in hormone receptor positive and HER2 negative breast cancer.
Journal: Molecular and clinical oncology
Published: February 08, 2018
DNA diagnosis of peritoneal fluid cytology test by CDO1 promoter DNA hypermethylation in gastric cancer.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: December 11, 2016
Homeobox-Only Protein Expression Is a Critical Prognostic Indicator of Pancreatic Neuroendocrine Tumor and Is Regulated by Promoter DNA Hypermethylation.
Journal: Pancreas
Published: October 25, 2016
Promoter DNA methylation of CDO1 gene and its clinical significance in esophageal squamous cell carcinoma.
Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Published: September 16, 2016
Epigenetic silencing of HOPX contributes to cancer aggressiveness in breast cancer.
Journal: Cancer letters
Published: February 10, 2016
Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapy.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 11, 2015
Last Updated: 09/26/2026